Search results for "Calcium metabolism"

showing 4 items of 64 documents

Magnesium metabolism in hypertension and type 2 diabetes mellitus.

2007

The increasing evidence for the clinical relevance of altered magnesium metabolism to states of altered insulin resistance confirms the role of magnesium deficit as a possible underlying common mechanism of the "insulin resistance" of hypertension and altered glucose tolerance. The pioneer work of Lawrence M. Resnick and his group using the cellular ion-based approach that we are only partially presenting here has consistently contributed to the progress of the field, demonstrating (a) the critical importance of magnesium metabolism in regulating insulin sensitivity as well as vascular tone, and blood-pressure homeostasis; (b) that magnesium deficiency, defined on the basis of intracellular…

medicine.medical_specialtyMagnetic Resonance Spectroscopychemistry.chemical_elementEssential hypertensionInsulin resistancePre-EclampsiaPregnancyMagnesium deficiency (medicine)Diabetes mellitusInternal medicinemedicineHumansPharmacology (medical)MagnesiumSodium Chloride DietaryPharmacologyCalcium metabolismMagnesiumbusiness.industryType 2 Diabetes MellitusGeneral MedicineSyndromemedicine.diseaseEndocrinologychemistryDiabetes Mellitus Type 2HypertensionCalciumFemaleInsulin ResistancebusinessMagnesium DeficiencyHomeostasisAmerican journal of therapeutics
researchProduct

n-3 Fatty Acids Modulate T-Cell Calcium Signaling in Obese Macrosomic Rats

2004

Objective: We investigated the effects of a diet containing EPAX-7010, rich in PUFAs such as eicosapentaenoic acid [20:5(n-3)] and docosahexaenoic acid [22:6(n-3)], i.e., a PUFA/EPAX regimen, on T-cell activation in diabetic pregnant rats and their obese pups. Research Methods and Procedures: Mild hyperglycemia in pregnant rats was induced by intraperitoneal injection of streptozotocin on Day 5 of gestation. T-cell blastogenesis was assayed by using 3H-thymidine, whereas intracellular free calcium concentrations ([Ca2+]i) were measured by using Fura-2 in diabetic pregnant rats and their obese offspring. Results: Concavalin-A-stimulated T-cell proliferation was decreased in both pregnant dia…

medicine.medical_specialtyOffspringT-LymphocytesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentIntraperitoneal injectionPregnancy in DiabeticsMedicine (miscellaneous)Gestational AgeLymphocyte ActivationDiabetes Mellitus ExperimentalFetal MacrosomiaEndocrinologyDietary Fats UnsaturatedPregnancyDiabetes mellitusInternal medicineFatty Acids Omega-3Concanavalin AmedicineAnimalsObesityRats Wistarchemistry.chemical_classificationCalcium metabolismbusiness.industryIonomycinPublic Health Environmental and Occupational Healthmedicine.diseaseStreptozotocinEicosapentaenoic acidRatsEndocrinologychemistryDocosahexaenoic acidThapsigarginCalciumFemalebusinessSpleenSignal TransductionFood SciencePolyunsaturated fatty acidmedicine.drugObesity Research
researchProduct

Duration of breastfeeding as a risk factor for vertebral fractures

2014

Abstract Purpose Among the risk factors for osteoporosis and fractures, gynecological history (fertile period, parity and breastfeeding) play an important part. Changes in calcium metabolism to enable an adequate mineral transfer to the milk have a prominent role in bone loss during breastfeeding. Data on the influence of breastfeeding in postmenopausal osteoporosis are inconsistent. The aim of the present study was to identify any association between duration of breastfeeding and vertebral fractures in postmenopausal women. Methods All patients underwent the following tests: bone mineral density measurements of the lumbar spine (L1–L4) and the total and femoral neck using dual-energy X-ray…

medicine.medical_specialtyTime FactorsHistologyPhysiologybreastfeedingEndocrinology Diabetes and MetabolismOsteoporosisBreastfeedingcalcium metabolismPregnancyRisk FactorsLactationConfidence IntervalsOdds RatiomedicineHumansvertebral fracturesRisk factorFemoral neckBone mineralPregnancybusiness.industryObstetricsrisk factors for osteoporosiMiddle Agedmedicine.diseaseSurgeryMenopauseBreast Feedingmedicine.anatomical_structureSpinal FracturesFemalebusiness
researchProduct

Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis.

1992

Recently it has been demonstrated that ipriflavone (IP), an isoflavone derivative, is able to increase bone mass in patients with established postmenopausal osteoporosis (PMO). Here we present a preliminary report of a 2-year multicenter, double-blind, placebo-controlled clinical study performed in order to evaluate the efficacy and tolerability of IP in PMO. A large number of patients with PMO, referred to 12 Italian centers, was randomly divided into 2 groups and treated with oral IP (600 mg/day) or placebo (Pl). All patients received an oral Ca supplement (1 g/day). One hundred and twenty six patients completed 1 year of the study. Bone mineral density (BMD) of the distal radius, measure…

medicine.medical_specialtyUrinary systemOsteoporosisUrologyPlaceboBiochemistryExcretionEndocrinologyDouble-Blind MethodBone DensityInternal medicinemedicineHumansOsteoporosis PostmenopausalAgedBone mineralCalcium metabolismbusiness.industryMiddle Agedmedicine.diseaseIsoflavonesEndocrinologyItalyTolerabilityCalciumFemaleSurgeryIpriflavonebusinessmedicine.drug
researchProduct